Results 131 to 140 of about 2,026 (172)

The Relationship Between Psychedelic Use and Positive Adult Development in Emerging Adulthood: An Integrative Review. [PDF]

Brain Behav
Payne J, Robinson O, Arnaud KS, Aday JS, Warner M, Ludlow C, Murray G.   +6 more
europepmc   +1 more source

Psilocybin in Neuropsychiatric Disorders: Seeking Valuable Evidence in History, Pure Science, Clinical Trials and Real-World Data (RWD). [PDF]

Brain Sci
Skalski P, Pękacka-Falkowska K, Pluto-Prądzyńska A, Owecki MK.   +3 more
europepmc   +1 more source

Healthcare Providers' Perspectives on Psychedelic-Assisted Therapies Across Clinical Contexts: "I Can Offer Medical Assistance in Dying, but I Can't Prescribe Psychedelics". [PDF]

Glob Adv Integr Med Health
Schuman HDM, Mina R, Barkova S, Nguyen T, Deleemans JM, Carlson LE.   +5 more
europepmc   +1 more source

Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major Depression: A Randomized Clinical Trial.

JAMA Netw Open
Yngwe H, Plavén-Sigray P, Ekman CJ, Henje E, Berglund A, Tiger M, Beckman M, Lundberg J.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Psychedelic Agents and Mysticism

Psychosomatics, 1971
• Mushrooms often complement a fine steak dinner but John M. Allegro in his recently published book, The Sacred Mushroom and the Cross,' has served up mushrooms in a rare combination. It is his contention that Judaism and Christianity developed out of pre-existing fertility cults in which worship of the mushroom Amanita muscaria was practiced.
exaly   +3 more sources

Psychedelic Drugs as Treatment Agents

Abstract Psychedelics are compounds that alter consciousness. Currently, most psychedelic substances are federally illegal in the United States; however, the U.S. Food and Drug Administration has designated three psychedelic-assisted psychotherapy treatments as breakthrough therapies.
Rachel Yehuda, Lauren A. Lepow, Philip A. Bonnano, Tamar Glatman Zaretsky, Josimar Hernandez Antonio, Kathleen M. Jagodnik   +5 more
exaly   +2 more sources

Is the psychedelic experience an essential aspect of the therapeutic effect of serotonergic psychedelics? Conceptual, discovery, development and implementation implications for psilocybin and related agents

Expert Opinion on Drug Safety, 2023
Roger Mcintyre
exaly   +3 more sources

Psychedelics as anti-inflammatory agents

International Review of Psychiatry, 2018
Serotonin (5-hydroxytryptamine, 5-HT)2A receptor agonists have recently emerged as promising new treatment options for a variety of disorders. The recent success of these agonists, also known as psychedelics, like psilocybin for the treatment of anxiety, depression, obsessive-compulsive disorder (OCD), and addiction, has ushered in a renaissance in the
Thomas W, Flanagan, Charles D, Nichols
openaire   +2 more sources

Psychedelic Agents in Creative Problem-Solving: A Pilot Study

Psychological Reports, 1966
Based on the frequently reported similarities between creative and psychedelic (drug-induced, consciousness-expansion) experiences, a preliminary study was conducted to explore the effects of psychedelic agents (LSD-25, mescaline) on creative problem-solving ability.
W W, Harman, R H, McKim, R E, Mogar, J, Fadiman, M J, Stolaroff   +4 more
openaire   +2 more sources

[Are psychedelics fast acting antidepressant agents?]

Der Nervenarzt, 2022
Psychedelics, such as psilocybin represent one of the most promising current therapeutic approaches in psychiatry.Psychedelics seem to have not only potent antidepressant effects. Do they also work particularly quickly, i.e. within one day?The available literature on clinical studies of psychedelics in depressive syndromes is presented both from the ...
Gerhard, Gründer, Manuela, Brand, Laura, Kärtner, Dennis, Scharf, Christian, Schmitz, Moritz, Spangemacher, Lea J, Mertens   +6 more
openaire   +1 more source